OR WAIT null SECS
Kevin Gopal is Pharmaceutical Executive's international correspondent, covering pharma and regulatory issues around the word. He is also a political columnist for North West Business Insider, one of the UK's leading regional business magazines. He started his career as a journalist at SiYu, the UK's Chinese community magazine, before joining the PE staff.
Rio de Janeiro-The Brazilian health ministry will use its $35 million a year in savings on Roche’s newly discounted AIDS therapy to fund a program aimed at providing non-AIDS medicines to low-income families.